Statistics for Nuvation Bio (id:9944 NUVB)

Valuation metrics

Market cap

885.17M

Enterprise value

347.23M

Trailing P/E (ttm)

-8.00

Forward P/E

-4.17

PEG ratio

-4.17

Price/Sales (ttm)

409.42

Price/Book (mrq)

1.76

Enterprise Value/Revenue

160.60

Enterprise Value/EBITDA

-2.59

Overview

Shares outstanding

335.57M

Float

233.83M

Shares short

11.32M

% Held by insiders

0.27%

% Held by institutions

0.56%

Average volume (10 days)

2.60M

Average volume (90 days)

Price summary

52-Week low

1.22

52-Week high

4.16

52-Week change

54.64%

Beta

1.36

50-Day moving average

2.55

200-Day moving average

2.76

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-6,616.37%

Operational effectiveness

Return on assets

-13.98%

Return on equity

-95.54%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-133,927,000.00

Net income to common (ttm)

-532,280,992.00

Diluted EPS (ttm)

-2.18

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

549.13M

Total cash per share (mrq)

1.63

Total debt (mrq)

11.19M

Total Debt/Equity (mrq)

2.23

Current ratio (mrq)

957.00%

Book value per share (mrq)

1.50

Cash flow

Cash flow statement

-99,140,000.00

Levered free cash flow (LFCF)

-33,288,250.00